Aptose Biosciences Inc.
APTOF
$2.20
$0.083.77%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.84% | -22.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -68.60% | -5.17% | |||
| Operating Income | 68.60% | 5.17% | |||
| Income Before Tax | 77.20% | 4.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 77.20% | 4.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 77.20% | 4.12% | |||
| EBIT | 68.60% | 5.17% | |||
| EBITDA | 68.64% | 5.12% | |||
| EPS Basic | 88.10% | 13.45% | |||
| Normalized Basic EPS | 88.10% | 13.45% | |||
| EPS Diluted | 88.10% | 13.45% | |||
| Normalized Diluted EPS | 88.10% | 13.45% | |||
| Average Basic Shares Outstanding | 91.56% | 10.78% | |||
| Average Diluted Shares Outstanding | 91.56% | 10.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||